DILIsym Releases NAFLDsym® Version 2A
Substantial update of NAFLD drug efficacy software offers a broad range of pathophysiology and over a thousand simulated patients for…
Pharmaceuticals, Biotechnology and Life Sciences
Substantial update of NAFLD drug efficacy software offers a broad range of pathophysiology and over a thousand simulated patients for…
— Patient Identification Nearing Completion for Global Phase 3 PolarisDMD Trial for Edasalonexent in Duchenne Muscular Dystrophy — CAMBRIDGE, Mass.–(BUSINESS…
CHICAGO–(BUSINESS WIRE)–Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch, today announced it…
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) hereby announces that it has filed its Annual Report on Form 20-F…
Third quarter highlights, year-over-year Sales increased 0.7 percent to $34.6 billion Operating income decreased 24.7 percent to $1.2 billion; Adjusted…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) today announced that Health Canada has completed the initial screening…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Coronary Artery Disease” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the…
PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today…
STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases…